Expression of ASPH Gene in Invasive Breast Cancer and Its Clinical Significance in Promoter Methylation

LI Chuan, LI Hong-jiang, CHEN Qu. et al

Abstract

To investigate the expression of mRNA of aspartyl/asparaginyl beta-hydroxylase (ASPH) gene in invasive breast cancer (IBC) and the relationship between methylation of gene promoter and clinicopathological parameters. Methods In 91 cases of breast cancer tissues and matched normal tissues (MNT), mRNA expression of the ASPH gene was detected by reverse transcription of real-time fluorescence quantification PCR and the methylation status of CpG island in the ASPH gene promoter region was detected by methylation specific PCR (MSP). And the relationship between the expression and the clinicopathological features of breast cancer was analyzed. Results The expression of ASPH gene mRNA in IBC was significantly higher than that in MNT (P<0. 001). The fold change of ASPH mRNA expression was related to whether E-cadherin was positive (r=0. 195,P=0. 041). The positive rate of methylation of ASPH gene promoter in breast cancer and MNT was 47.3% (43/91) and 89.0% (81/91). The methylation rate of gene promoter was correlated with E-cadherin and tumor size (P<0. 05). Conclusion The mRNA expression and promoter methylation rate of ASPH gene may play a role in the development and progression of breast cancer.

 

Keywords: Invasive breast cancer, Methylation,ASPH

 

Full Text:

PDF


References


DOU QH.CHEN HN.WANG К. Et al. Ivermectin induces cytostatic autophagy by blocking the PAKl/Akt axis in breast cancer. Cancer Res.2016.76( 15) :4457-4469.

CHEN W,ZHENG R. BAADE PD,et al. Cancer statistics in China 2015. CA Cancer J Clin,2016.66(2): 115-132.

XUE T, SU J, LI H, et al. Evaluation of HAAH/humbug quantitative detection in the diagnosis of hepatocellular carcinoma. Oncol Rep.2015.33(1) :329-337.

LEE JH. Overexpression of humbug promotes malignant progression in human gastric cancer cells. Oncol Rep. 2008. 19(3);795-800.

DONG X.LIN Q.AIHARA A, et al. Aspartate-hydroxylase expression promotes a malignant pancreatic cellular phenotype. Oncotarget .2015,6(2); 1231-1248.

KORIOTH F. GIEFFERS С. FREY J. Cloning and characterization of the human gene encoding aspartyl beta- hydroxylase. Gene, 1994 .150(2) ;395-399.

] STURLA LM, TONG M, HEBDA N, et al. Aspartate-p- hydroxylase ( ASPH ); a potential therapeutic target in human malignant gliomas. Heliyon, 2016, 2 ( 12 ); e00203 [2016-11-21]. https://doi. org/10. 1016/j. heliyon. 2016. e00203.

DEBIES MT, WELCH DR. Genetic basis of human breast cancer metastasis. J Mammary Gland Biol Neoplasia,2001,6 (4);441-451.

TIAN H, MCKNIGHT SU RUSSELL DW. Endothelial PAS domain protein 1 ( EPAS1 ), a transcription factor selectively expressed in endothelial cells. Genes Dev,1997,ll (1): 72-82.

IVAN M, KONDO K, YANG H, el at. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation; implications for 02 sensing. Science, 2001, 292 ( 5516): 464- 468.

MAXWELL PH, WIESENER MS, CHANG GW. et al. The tumour suppressor protein VHL targets hypoxia- inducible factors for oxygen-dependent proteolysis. Nature, 1999,399(6733) :271-275.


Refbacks

  • There are currently no refbacks.